CareCloud (CCLD) director Sharnak converts 6,250 RSUs into common stock

(Neutral)

Form Type

Rhea-AI Filing Summary

CareCloud director Lawrence Steven Sharnak reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of CareCloud common stock at a price of $0 per share under the company’s Amended and Restated Equity Incentive Plan.

After this transaction, Sharnak directly owned 120,250 shares of common stock and 33,750 restricted stock units. The award vested without cash payment by the reporting person, reflecting compensation delivered in company equity rather than cash.

Insider Trade Summary

Net Buyer: 6,250 shares

Net Buy 2 txns

Insider Sharnak Lawrence Steven

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	6,250	$0.00	$0.00
Exercise	Common Stock	6,250	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 33,750 shares (Direct); Common Stock — 120,250 shares (Direct)

Footnotes (1)

F1. Represents the conversion upon vesting of restricted stock units into common stock on January 31, 2026. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/03/2026 - 09:30 PM

FAQ

What insider transaction did CareCloud (CCLD) director Lawrence Sharnak report?

CareCloud director Lawrence Steven Sharnak reported the vesting of 6,250 restricted stock units into 6,250 shares of common stock. The conversion occurred on January 31, 2026, as part of his equity compensation, at a stated price of $0 per share.

How many CareCloud (CCLD) shares does Lawrence Sharnak own after this Form 4?

After the reported transaction, Lawrence Steven Sharnak directly owned 120,250 shares of CareCloud common stock. He also held 33,750 restricted stock units, providing additional potential future share ownership as those units vest under the company’s Amended and Restated Equity Incentive Plan.

Was cash paid for the CareCloud (CCLD) shares received by Lawrence Sharnak?

No cash was paid for these shares. The filing states the restricted stock units and the resulting shares of common stock were acquired under CareCloud’s Amended and Restated Equity Incentive Plan without payment by the reporting person, reflecting non-cash equity compensation.

What does transaction code "M" mean in Lawrence Sharnak’s CareCloud (CCLD) Form 4?

Transaction code "M" indicates an exercise or conversion of a derivative security. Here, 6,250 restricted stock units converted into 6,250 shares of CareCloud common stock on January 31, 2026, consistent with the vesting terms of the company’s equity incentive plan.

How many restricted stock units in CareCloud (CCLD) does Lawrence Sharnak hold after vesting?

Following the January 31, 2026 vesting event, Lawrence Steven Sharnak beneficially owned 33,750 restricted stock units. These units represent a right to receive additional CareCloud common shares in the future as they vest, subject to the plan’s terms and conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharnak Lawrence Steven

(Last)

(First)

(Middle)

7 CLYDE ROAD

(Street)

SOMERSET

08873

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CareCloud, Inc. [ CCLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/31/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/31/2026		M		6,250	A	$0⁽¹⁾	120,250	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	$0⁽¹⁾	01/31/2026		M			6,250	⁽¹⁾	⁽¹⁾	Common Stock	6,250	$0⁽¹⁾	33,750	D

Explanation of Responses:

1. Represents the conversion upon vesting of restricted stock units into common stock on January 31, 2026. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.

	/s/ Norman Roth Attorney-In-Fact for Lawrence S. Sharnak	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR